Conclusion
This descriptive study characterizes the
neuropsychological performance of individuals with
methamphetamine-induced psychosis. Continuing to
investigate cognitive performance in MAP patients
in Thailand and in other countries will provide a
better understanding of the etiology and consequences
of MAP.
Additionally, neuropsychological
testing may be a valid diagnostic tool to distinguish
methamphetamine abuse from methamphetamineinduced
psychosis, or to inform clinicians trying
to treat individuals with MAP.